311 related articles for article (PubMed ID: 17393376)
1. Increased cancer incidence after radioiodine treatment for hyperthyroidism.
Metso S; Auvinen A; Huhtala H; Salmi J; Oksala H; Jaatinen P
Cancer; 2007 May; 109(10):1972-9. PubMed ID: 17393376
[TBL] [Abstract][Full Text] [Related]
2. Increased long-term cardiovascular morbidity among patients treated with radioactive iodine for hyperthyroidism.
Metso S; Auvinen A; Salmi J; Huhtala H; Jaatinen P
Clin Endocrinol (Oxf); 2008 Mar; 68(3):450-7. PubMed ID: 17941909
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
[TBL] [Abstract][Full Text] [Related]
4. Cancer Incidence and Mortality in Patients Treated Either With RAI or Thyroidectomy for Hyperthyroidism.
Ryödi E; Metso S; Jaatinen P; Huhtala H; Saaristo R; Välimäki M; Auvinen A
J Clin Endocrinol Metab; 2015 Oct; 100(10):3710-7. PubMed ID: 26262435
[TBL] [Abstract][Full Text] [Related]
5. Increased cardiovascular and cancer mortality after radioiodine treatment for hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Auvinen A; Oksala H; Salmi J
J Clin Endocrinol Metab; 2007 Jun; 92(6):2190-6. PubMed ID: 17374710
[TBL] [Abstract][Full Text] [Related]
6. Radioiodine treatment of hyperthyroidism. Success rate and influence of thyrostatic medication.
Ghadban WK; Zirie MA; Al-Khateeb DA; Jayyousi AA; Mobayedh HM; El-Aloosy AS
Saudi Med J; 2003 Apr; 24(4):347-51. PubMed ID: 12754531
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G
Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
[TBL] [Abstract][Full Text] [Related]
8. Risk of thyroid cancer after exposure to 131I in childhood.
Cardis E; Kesminiene A; Ivanov V; Malakhova I; Shibata Y; Khrouch V; Drozdovitch V; Maceika E; Zvonova I; Vlassov O; Bouville A; Goulko G; Hoshi M; Abrosimov A; Anoshko J; Astakhova L; Chekin S; Demidchik E; Galanti R; Ito M; Korobova E; Lushnikov E; Maksioutov M; Masyakin V; Nerovnia A; Parshin V; Parshkov E; Piliptsevich N; Pinchera A; Polyakov S; Shabeka N; Suonio E; Tenet V; Tsyb A; Yamashita S; Williams D
J Natl Cancer Inst; 2005 May; 97(10):724-32. PubMed ID: 15900042
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer following iodine-131 therapy for hyperthyroidism.
Hoffman DA; McConahey WM
J Natl Cancer Inst; 1983 Jan; 70(1):63-7. PubMed ID: 6571923
[TBL] [Abstract][Full Text] [Related]
10. Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post-therapeutic outcome.
Walter MA; Christ-Crain M; Eckard B; Schindler C; Nitzsche EU; Müller-Brand J; Müller B
Eur J Clin Invest; 2004 May; 34(5):365-70. PubMed ID: 15147334
[TBL] [Abstract][Full Text] [Related]
11. Cancer Risk After Radioactive Iodine Treatment for Hyperthyroidism: A Systematic Review and Meta-analysis.
Shim SR; Kitahara CM; Cha ES; Kim SJ; Bang YJ; Lee WJ
JAMA Netw Open; 2021 Sep; 4(9):e2125072. PubMed ID: 34533571
[TBL] [Abstract][Full Text] [Related]
12. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
13. Radiation dose and risk of soft tissue and bone sarcoma after breast cancer treatment.
Rubino C; Shamsaldin A; Lê MG; Labbé M; Guinebretière JM; Chavaudra J; de Vathaire F
Breast Cancer Res Treat; 2005 Feb; 89(3):277-88. PubMed ID: 15754127
[TBL] [Abstract][Full Text] [Related]
14. What influences early hypothyroidism after radioiodine treatment for Graves' hyperthyroidism?
Vijayakumar V; Ali S; Nishino T; Nusynowitz M
Clin Nucl Med; 2006 Nov; 31(11):688-9. PubMed ID: 17053385
[TBL] [Abstract][Full Text] [Related]
15. Cancer risks after diagnostic doses of 131I with special reference to thyroid cancer.
Holm LE
Cancer Detect Prev; 1991; 15(1):27-30. PubMed ID: 2044071
[TBL] [Abstract][Full Text] [Related]
16. Salivary gland side effects commonly develop several weeks after initial radioactive iodine ablation.
Grewal RK; Larson SM; Pentlow CE; Pentlow KS; Gonen M; Qualey R; Natbony L; Tuttle RM
J Nucl Med; 2009 Oct; 50(10):1605-10. PubMed ID: 19759114
[TBL] [Abstract][Full Text] [Related]
17. Impact of radiotherapy in the risk of esophageal cancer as subsequent primary cancer after breast cancer.
Salminen EK; Pukkala E; Kiel KD; Hakulinen TT
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):699-704. PubMed ID: 16626885
[TBL] [Abstract][Full Text] [Related]
18. Current treatment of nodular goiter with hyperthyroidism (Plummer's disease): surgery versus radioiodine.
Kang AS; Grant CS; Thompson GB; van Heerden JA
Surgery; 2002 Dec; 132(6):916-23; discussion 923. PubMed ID: 12490836
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy outcome after diagnosis of differentiated thyroid carcinoma: no deleterious effect after radioactive iodine treatment.
Chow SM; Yau S; Lee SH; Leung WM; Law SC
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):992-1000. PubMed ID: 15234032
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of the risk of developing hyperparathyroidism after 131I treatment for thyrotoxicosis.
Fjälling M; Dackenberg A; Hedman I; Tisell LE
Acta Chir Scand; 1983; 149(7):681-6. PubMed ID: 6650083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]